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Introduction
ecent studies suggest that opioids can have an adverse impact on the immune system and opioids use and abuse has been linked to significant immune-suppression, which renders individuals susceptible to infection. A variety of mechanisms have been proposed to explain how opioids suppress the immune system.Modulation of the inflammatory response appears to be a target of these compounds, including effects on phagocytic activity and response of cells to various chemo-attractant molecules, also opioids treatment has an impact on antibody responses through modulation of both cytokines and cytokine receptor expression (Liu et al., 2008) .
Moreover several studies found that morphine can decrease the effectiveness of several functions of both natural and adaptive immunity, and significantly reduces cellular immunity leading to increased morbidity and mortality due to infection .
However, it emerges that not all opioids induce the same immune-suppressive effects, and evaluating each opioid profile is important for appropriate analgesic selection (Sacerdote, 2006) .
Tramadol is a synthetic opioid analgesic, it is commonly prescribed for moderate to severe pain and became abused, more popular among teens, in most countries (McKeon et al., 2011) . Tramadol provides analgesia through 3 mechanisms: mu-opioid binding, serotonin reuptake inhibition and nor-epinephrine reuptake inhibition (Sansone and Sansone, 2009) . It has been claimed that, in contrast to most opioids, tramadol does not suppress immune functions.
Aim of the work
The aim of this study is evaluate the effect of tramadol on immune system by measuringCD4+percent in patients presented with acute suicidal tramadol overdose to the Poison Control Centre (PCC), Ain Shams University Hospitals. 
Patients and methods

Type of the study
Exclusion criteria
Patients presented with sepsis, shock, drug abuse, opiate intake, history of alcoholic intake, chronic illness or hepatitis were excluded from the study due to the possible effect of these diseases on immunity.
Biochemical parameters
Blood samples were taken after admission for assay of lymphocytic percent and CD4 percent. Also serum hepatitis B surface antigen (HBV S Ag), hepatitis C antibodies (HCV AB) and human immune deficiency virus antibodies (HIV AB) were done on admission to exclude positive cases from the study.
Urine samples were taken after admission for tramadol and opiate screen to prove the tramadol cases and exclude the opiate cases from the study.
I. Expressions of CD4+ in blood samples were measured as percentages of total lymphocytes by flow cytometer (FACS, BD, United States) by obtaining 3 ml blood samples of each patient from non-infused median cubital vein and keeping it in an EDTA-anti-coagulation tube (Becton-Dickinson, Heidelberg, Germany); incubating the blood with CD4+ monoclonal antibodies (BD, United States) at 25 C o for 30 minutes; lysing erythrocytes with hemolysin (BD, America; and dilated with distilled water at the ratio 1 : 9) for 10 minutes then centrifuging it at 1100 rpm (revolutions per minute) for 5 minutes; removing the supernatant, washing the cells with phosphatebuffered saline solution (PBS) 2 ml then centrifuging it at 1100 rpm for 5 minutes; removing the supernatant, adding 1% formamint-satured PBS to float blood cells then keeping it at 4 C o without light for 2-4 hours; using flow cytometry to measure the expressions of CD4+ as the percentages of total lymphocytes. II.
Hepatitis C antibodies, hepatitis B surface antigen and human immune deficiency virus test done by ELISA using Elisa kits. III.
Tramadol and opiate detection was done by capillary gas chromatography using DANI GC 1000 made in Italy ( Shung-Tai et al. 1999 ). The Ethics Committee approved the protocol of this trial. Relatives of recruited patients provided written informed consent for participation.
Statistical analysis:
The data was analyzed using SPSS statistical software (11.5.0; SPSS Inc., Chicago, IL). Differences between both groups were tested using student (t) test. A p value < 0.05 is considered statistically significant.
Results
Thirty patients with acute suicidal tramadol overdose were taken up for the study and 10 healthy people were taken as a control. (Table 1) shows that the mean lymphocyte percent (% )for the tramadol group was 9.6 ± 2.9, while the mean lymphocyte % for the control group was 29.4± 7.1 and there is significant decrease in the total lymphocyte percent in the tramadol group when compared with the control group with P value 0.0001. (Table 2) shows that the mean CD4% for the tramadol group was 28.6± 9.3, while the mean CD4 % for the control group was 39.3±6.3and there is significant decrease in the CD4% in the tramadol group with P value 0.004. (Table 3) shows that HBV SAg, HCV AB, HIV AB and opiate screen were negative in the tramadol and control groups and tramadol screen was positive in the tramadol group. 
Discussion
Tramadol use and abuse became more popular in most countries. Being an opioid, tramadol carries all possible risks known from other opiates (Adams et al., 2006) .Opioids have different effects on immunity via direct actions on neutrophils, monocytes, natural killer (NK) and T cells (Boland et al., 2013) .
The inhibitory effect of opioids on phagocytic cell capacity is well established. However, the effect of synthetic opioids on this aspect of cell function is controversial. Our results of studying 30 patients with acute suicidal tramadol overdose revealed significant decrease in the lymphocyte percent and CD4expression in the tramadol group when compared with the control group.
Similarly Wang et al., 2006 studied45 patients undergoing elective gastric cancer surgeries under general anaesthesia, they randomly allocated into 3 groups. Group I received morphine after surgery, group II using tramadol, and group III using tramadol with lornoxicam. Expressions of CD3, CD4, CD8, were measured as percentages of total lymphocytes and they found that using combination of lornoxicam with tramadol has the same good analgesic efficacy and less immunity depression than using morphine or tramadol.
Also Qian et al., 2005 found that suppression of immunity due to tramadol was dose dependant where they studied 20 outpatients without any immune diseases; their peripheral blood was collected and pre-treated with different concentrations of morphine or tramadol for 48 h, while the control group received neither. He found remarkable Th2 (T helper 2) differentiation after pretreatment with morphine or tramadol. IL-4 and IL-10 elevated significantly while IL-2 and IFN-γ decreased significantly compared with control groups. They also found that the suppression of cell-mediated immunity was dose dependent and Th2 differentiation was closely associated with the levels of cytokines, which was the cause of the immune alteration. It indicates that excessively high concentration of these drugs should be avoided in clinical applications in order to maintain a healthy Th1/Th2 balance. Also they said that both morphine and tramadol could direct human T-helper cell into Th2.
In contrast Zhou et al., 2013 in their prospective randomized controlled trial on 30 patients undergoing elective gastric cancer surgeries observe the effect of tramadol on T-lymphocyte subsets(CD3 +, CD4 +, CD8 +) and natural killer(NK)cells.
They found that tramadol in therapeutic dose can reduce the decrease of T-lymphocytes subsets and NK cells that found due to gastric cancer and stress of the operation, thus improve the cellular immune function in the peri-operation of gastric cancer.
Moreover Mostafa et al., 2012 performed a study on 70patients complaining of cancer related pain to evaluate effect of morphine versus tramadol on the immune response during management of patients with chronic cancer pain. They found that, the concentration of IL-2and INF γ in the serum of patients in morphine group was decreased significantly than that in the pretreatment phase while increased in the tramadol group than the pre-treatment phase and these changes were statistically significant. Both IL-2 and INF γ were significantly higher in tramadol group than morphine group along studied periods.
Also Shirzad etal., 2009 studied the effects of tramadol in comparison to morphine, on the number of mouse peritoneal phagocyte.
Ten days after the start of drug administration, the number of phagocytes reduced in morphine group (P < 0.05), and enhanced in tramadol group (P < 0.05) and they concluded that tramadol stimulation of immune system may offer a good alternative to morphine for the treatment of patients in whom immune-suppression might be hazardous or in patients who cannot tolerate the side effects of morphine. In another way Barkin 2008 found that increasing serotonin and nor epinephrine reduce inflammatory cytokines which are released by the brain in response to stress.
The inflammatory cytokines would have slowed recovery from a workout or illness impairing one's immune system and healing, also the increase of serotoninergic tone has usually been associated with stimulation of NK activity and lymphocyte proliferation thus tramadol may have an anti-inflammatory effect. Moreover Beilin et al., 2005 studied healthy volunteers, where peripheral blood polymorphonuclear cells and monocytes were incubated with tramadol, or with morphine.
After incubation for 60 minutes the percentage of cells engulfing latex particles and the phagocytic index (number of particles phagocytized by each individual cell) were detected. They found that tramadol did not affect neither the percentage of cells phagocyting latex particles, nor the phagocytic index of both polymorphonuclear cells and monocytes. On the other hand, morphine caused significant decrease in phagocytosis of monocytes phagocyting latex particles and decrease in the monocyte phagocyting index.
They concluded that the lack of noxious effect of tramadol on the engulfing capacity of phagocytic cells suggests additional benefit to the relatively safe profile of the drug.
Our explanation for the confliction between our results and the opposing opinion, that we studied the effect of larger doses of tramadol on CD4 % (as a marker of immunity), while they were using therapeutic dose of tramadol in their studies. So we warn about using higher dosage of tramadol in management of pain (especially due to rapid tolerance effect) because it may had reverse effect on immunity similar to other opioids.
Conclusion
We can conclude that tramadol overdose had a suppressive effect on lymphocyte proliferation and CD4 expression.
Recommendations
Further studies needed to test the effect of different doses of tramadol on immunity to document its safety as analgesic in immune-compromised patients.
